About acetylcysteine (Shi Fu Lu) on the evaluation of pulmonary function in patients with COPD.docVIP

 PAGE \* MERGEFORMAT 8 About acetylcysteine (Shi Fu Lu) on the evaluation of pulmonary function in patients with COPD [Abstract] Objective To observe the long-term oral Lu-rich applications on the remission of chronic obstructive pulmonary disease (COPD) in patients with heart and lung function, and thus ways of improving exercise capacity in patients with COPD and effective way to approach the quality of life of 40 patients with persistent oral Cedar Fu Lu 8 months of remission in patients with COPD, pulmonary function testing before and after the result of medication taken Shi Fu Lu, 8 months lung function in patients with COPD, including forced expiratory volume in 1 second (FEVl), forced vital capacity (FVC), rate of 1 sec (FEVl / FVC), maximal voluntary ventilation (MVV) were significantly increased. Statistically significant (P lt;O.05) concluded long-term oral Lu Shi Fu to improve cardiopulmonary function in patients with COPD in remission. [Keywords: chronic obstructive pulmonary disease, pulmonary Shi Fu Lu Chronic obstructive pulmonary disease (COPD), Department of the distal part of terminal bronchioles (including respiratory bronchioles, alveolar ducts, alveolar sacs and alveolar) expansion, and gas associated with parietal damage. At home and abroad of remission in patients with COPD not sure of effective control methods. Fu Lu Shi (NAC) of its active ingredient N-acetyl cysteine. with expectoration, sputum soluble, antioxidant, anti-inflammatory, increase ciliary movement and the clearance and other effects, new drug to treat COPD. In this study of 40 patients with persistent oral Fu Lu 8 months Cedar remission in patients with COPD were followed up to determine their lung function to examine the long-term oral NAC on lung function in patients with remission of COPD, which finding a cure for COPD patients in remission simple and easy method. 1 Clinical data 1.1 General Information The group of 40 patients with COPD patients